These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12132459)

  • 1. Anti-HIV agents. Long-term use of hydroxyurea.
    TreatmentUpdate; 2000 Sep; 12(6):2-3. PubMed ID: 12132459
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea in HIV therapy.
    HIV Hotline; 1998 Mar; 8(1):5-7. PubMed ID: 11365359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
    Lori F; Pollard RB; Whitman L; Bakare N; Blick G; Shalit P; Foli A; Peterson D; Tennenberg A; Schrader S; Rashbaum B; Farthing C; Herman D; Norris D; Greiger P; Frank I; Groff A; Lova L; Asmuth D; Lisziewicz J
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):263-72. PubMed ID: 15943568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations.
    Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C
    HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Hydroxyurea for real?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
    Paton NI; Aboulhab J
    HIV Med; 2005 Jan; 6(1):13-20. PubMed ID: 15670247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea for HIV?
    Treat Rev; 1998; (No 28):10-2. PubMed ID: 11365419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMPA trials recruiting.
    AIDS Treat News; 1998 Sep; (303):5-6. PubMed ID: 11365766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of hydroxyurea in HIV-1 infected patients.
    Frank I
    J Biol Regul Homeost Agents; 1999; 13(3):186-91. PubMed ID: 10560754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea for HIV infection.
    Zachary KC; Davis B
    AIDS Clin Care; 1998 Apr; 10(4):25-6, 32. PubMed ID: 11365149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide.
    Vila J; Nugier F; Barguès G; Vallet T; Peyramond D; Hamedi-Sangsari F; Seigneurin JM
    Lancet; 1997 Aug; 350(9078):635-6. PubMed ID: 9288048
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term suppression of HIV-1 by hydroxyurea and didanosine.
    Lori F; Jessen H; Foli A; Lisziewicz J; Matteo PS
    JAMA; 1997 May; 277(18):1437-8. PubMed ID: 9145714
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles of treating HIV.
    Johnson D
    S Afr Med J; 2000 Mar; 90(3):227-30. PubMed ID: 10853393
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV therapy update.
    Proj Inf Perspect; 2001 Mar; (32):4-6. PubMed ID: 11682776
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.
    Frank I; Bosch RJ; Fiscus S; Valentine F; Flexner C; Segal Y; Ruan P; Gulick R; Wood K; Estep S; Fox L; Nevin T; Stevens M; Eron JJ;
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):916-26. PubMed ID: 15597521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another take on when to start and how to succeed.
    Friedland GH
    AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyurea continues to show promise.
    Santiago L
    GMHC Treat Issues; 1996 Feb; 10(2):9-11. PubMed ID: 11363387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1.
    Paton NI; Aboulhab J; Karim F
    Lancet; 2002 May; 359(9318):1667-8. PubMed ID: 12020529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.